AIM2ACT: Randomized controlled trial protocol for a mobile health intervention for early adolescents with asthma.
AIM2ACT: Randomized controlled trial protocol for a mobile health intervention for early adolescents with asthma.
复制标题
DOI：
10.1016/j.cct.2022.107011
复制
发表时间：
2022-12
影响因子：
2.2
通讯作者：
Prabhakaran, Sreekala
中科院分区：
文献类型：
--
作者：
Fedele, David A.;Thomas, J. Graham;McQuaid, Elizabeth L.;Gurka, Matthew;Berg, Cynthia A.;Prabhakaran, Sreekala
早期诊断为哮喘的青少年难以持续地进行疾病自我管理行为，使他们面临哮喘控制不良、发病率和生活质量下降的风险。帮助照顾者的支持是决定早期青少年是否发展和掌握哮喘自我管理行为的关键。我们开发了将交互式移动的健康应用于青少年哮喘护理（AIM 2ACT），这是一种移动的健康干预措施，旨在促进哮喘控制不良的早期青少年（12-15岁）的护理人员支持。AIM 2ACT是一种二元智能手机干预，包含三个组成部分：1）生态瞬时评估，以确定哮喘自我管理行为的个性化优势和弱点; 2）协作识别和跟踪帮助早期青少年在管理哮喘方面变得越来越独立的目标;和3）一套技能培训视频。本文描述了我们的计划，以测试AIM 2ACT的疗效，并评估长期维持治疗效果的充分动力随机对照试验与160个早期青少年控制不佳的持续性哮喘，年龄12-15岁，和照顾者。家庭将被随机分配接受AIM 2ACT（n=80）或mHealth注意力控制条件（n=80），该条件说明了基于技术的干预的注意力和新奇，为期6个月。将在基线、干预后以及3个月、6个月和12个月随访时间点进行评估。我们将收集患者报告和客观监测（例如，肺量测定、依从性）结果。鉴于试验的时间安排，第二个探索性目标是在我们的干预背景下评估COVID-19对家庭功能和父母控制青少年哮喘的影响。
Early adolescents diagnosed with asthma have difficulties consistently performing disease self-management behaviors, placing them at-risk for poor asthma control, morbidity, and reduced quality of life. Helpful caregiver support is pivotal in determining whether early adolescents develop and master asthma self-management behaviors. We developed Applying Interactive Mobile health to Asthma Care in Teens (AIM2ACT), a mobile health intervention to facilitate helpful caregiver support in early adolescents (12–15 year-olds) with poorly controlled asthma. AIM2ACT is a dyadic smartphone intervention that contains three components: 1) ecological momentary assessment to identify personalized strengths and weaknesses in asthma self-management behaviors; 2) collaborative identification and tracking of goals that help early adolescents to become increasingly independent in managing their asthma; and 3) a suite of skills training videos. This paper describes our plans to test the efficacy of AIM2ACT and evaluate long-term maintenance of treatment effects in a fully powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12–15 years, and a caregiver. Families will be randomly assigned to receive AIM2ACT (n=80) or a mHealth attention control condition (n=80) that accounts for attention and novelty of a technology-based intervention for 6 months. Assessments will occur at baseline, post-intervention, and 3-, 6-, and 12-month follow-up time points. We will collect patient-reported and objectively monitored (e.g., spirometry, adherence) outcomes. Given the timing of the trial, a secondary exploratory goal is to evaluate the perceived impact of COVID-19 on family functioning and parental control of their adolescent’s asthma in the context of our intervention.
登录
查看更多内容
影响因子：
8
作者：
Butz, Arlene M.;Tsoukleris, Mona;Bollinger, Mary E.
通讯作者：
Bollinger, Mary E.
影响因子：
1.9
作者：
Bruzzese, Jean-Marie;Stepney, Cesalie;Evans, David
通讯作者：
Evans, David
影响因子：
4.2
作者：
Bruzzese, Jean-Marie;Carcone, April Idalski;Naar-King, Sylvie
通讯作者：
Naar-King, Sylvie
影响因子：
5.9
作者：
Bender, B;Wamboldt, FS;Wamboldt, MZ
通讯作者：
Wamboldt, MZ
影响因子：
1.6
作者：
Clark, Noreen M.;Dodge, Julia A.;Paton, James Y.
通讯作者：
Paton, James Y.